These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 10066249)

  • 1. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.
    Nunomura A; Perry G; Pappolla MA; Wade R; Hirai K; Chiba S; Smith MA
    J Neurosci; 1999 Mar; 19(6):1959-64. PubMed ID: 10066249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease.
    Nunomura A; Chiba S; Lippa CF; Cras P; Kalaria RN; Takeda A; Honda K; Smith MA; Perry G
    Neurobiol Dis; 2004 Oct; 17(1):108-13. PubMed ID: 15350971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.
    Zhang J; Perry G; Smith MA; Robertson D; Olson SJ; Graham DG; Montine TJ
    Am J Pathol; 1999 May; 154(5):1423-9. PubMed ID: 10329595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.
    Nunomura A; Tamaoki T; Motohashi N; Nakamura M; McKeel DW; Tabaton M; Lee HG; Smith MA; Perry G; Zhu X
    J Neuropathol Exp Neurol; 2012 Mar; 71(3):233-41. PubMed ID: 22318126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies.
    Nunomura A; Chiba S; Kosaka K; Takeda A; Castellani RJ; Smith MA; Perry G
    Neuroreport; 2002 Nov; 13(16):2035-9. PubMed ID: 12438921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial abnormalities in Alzheimer's disease.
    Hirai K; Aliev G; Nunomura A; Fujioka H; Russell RL; Atwood CS; Johnson AB; Kress Y; Vinters HV; Tabaton M; Shimohama S; Cash AD; Siedlak SL; Harris PL; Jones PK; Petersen RB; Perry G; Smith MA
    J Neurosci; 2001 May; 21(9):3017-23. PubMed ID: 11312286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
    Kharel P; McDonough J; Basu S
    Neurochem Int; 2016 Jan; 92():43-8. PubMed ID: 26706235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.
    Honda K; Smith MA; Zhu X; Baus D; Merrick WC; Tartakoff AM; Hattier T; Harris PL; Siedlak SL; Fujioka H; Liu Q; Moreira PI; Miller FP; Nunomura A; Shimohama S; Perry G
    J Biol Chem; 2005 Jun; 280(22):20978-86. PubMed ID: 15767256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease.
    Te Koppele JM; Lucassen PJ; Sakkee AN; Van Asten JG; Ravid R; Swaab DF; Van Bezooijen CF
    Neurobiol Aging; 1996; 17(6):819-26. PubMed ID: 9363791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative damage is the earliest event in Alzheimer disease.
    Nunomura A; Perry G; Aliev G; Hirai K; Takeda A; Balraj EK; Jones PK; Ghanbari H; Wataya T; Shimohama S; Chiba S; Atwood CS; Petersen RB; Smith MA
    J Neuropathol Exp Neurol; 2001 Aug; 60(8):759-67. PubMed ID: 11487050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA and RNA oxidative damage in the retina is associated with ganglion cell mitochondria.
    Gu L; Kwong JM; Caprioli J; Piri N
    Sci Rep; 2022 May; 12(1):8705. PubMed ID: 35610341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of oxidized RNAs in Alzheimer's disease.
    Shan X; Lin CL
    Neurobiol Aging; 2006 May; 27(5):657-62. PubMed ID: 15979765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease.
    Mecocci P; MacGarvey U; Beal MF
    Ann Neurol; 1994 Nov; 36(5):747-51. PubMed ID: 7979220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
    Nunomura A; Hofer T; Moreira PI; Castellani RJ; Smith MA; Perry G
    Acta Neuropathol; 2009 Jul; 118(1):151-66. PubMed ID: 19271225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease.
    Wang J; Xiong S; Xie C; Markesbery WR; Lovell MA
    J Neurochem; 2005 May; 93(4):953-62. PubMed ID: 15857398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures.
    Ding Q; Dimayuga E; Markesbery WR; Keller JN
    J Neurochem; 2004 Dec; 91(5):1211-8. PubMed ID: 15569264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
    Nunomura A; Perry G; Pappolla MA; Friedland RP; Hirai K; Chiba S; Smith MA
    J Neuropathol Exp Neurol; 2000 Nov; 59(11):1011-7. PubMed ID: 11089579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy.
    Miyata R; Hayashi M; Tanuma N; Shioda K; Fukatsu R; Mizutani S
    J Neurol Sci; 2008 Jan; 264(1-2):133-9. PubMed ID: 17949751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
    Smith MA; Nunomura A; Zhu X; Takeda A; Perry G
    Antioxid Redox Signal; 2000; 2(3):413-20. PubMed ID: 11229355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.